EML4 and neoplasm: Our study, using FISH and Sanger sequencing, has found that EML4-ALK variant 1 produced a fused circular RNA termed F-circEA1, which affected tumor proliferation, migration, invasion, apoptosis and cell cycle, and had resistance to the molecularly targeted drug crizotinib in H3122 cells.